News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Hepatocellular Carcinoma associated with NAFLD in South Texas

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

In this study we aim (1) to determine the tumor genomic landscape of NASH-associated Hepatocellular Carcinomas in patients in South Texas and, (2) to detect selected somatic mutations in plasma cfDNA in patients with NASH-associated Hepatocellular Carcinoma, using a custom-designed targeted sequencing panel.

Information: 

Principal Investigator
Jose Almeda, MD
Type of Trial
Prospective
© 2023 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram